Chronic hepatitis in carriers of hepatitis B surface antigen, with intrahepatic expression of the delta antigen. An active and progressive disease unresponsive to immunosuppressive treatment

M. Rizzetto, G. Verme, S. Recchia, F. Bonino, P. Farci, S. Aricò, R. Calzia, A. Picciotto, M. Colombo, H. Popper

Research output: Contribution to journalArticle

Abstract

To assess the characteristics of chronic hepatitis in hepatitis B surface antigen (HBsAg) carriers with intrahepatic delta antigen, the hepatic histologic findings of 137 patients were reviewed; 101 patients were followed for 2 to 6 years. The predominant liver disease was chronic active hepatitis in 93 patients or cirrhosis in 32; minor forms of chronic persistent or lobular hepatitis were seen in 12 patients. Eight of the 26 patients with an initial diagnosis of cirrhosis died during the follow-up period. Cirrhosis developed in 31 of 75 patients (41%) without nodular regeneration seen in the first biopsy specimen; 5 of these patients died. Treatment with prednisone or azathioprine did not induce histologic amelioration of delta hepatitis or prevent cirrhosis. Chronic HBsAg hepatitis with intrahepatic expression of the delta antigen is an active, progressive disease unresponsive to conventional immunosuppressive treatment.

Original languageEnglish
Pages (from-to)437-441
Number of pages5
JournalAnnals of Internal Medicine
Volume98
Issue number4
Publication statusPublished - 1983

Fingerprint

Hepatitis delta Antigens
Chronic Hepatitis
Immunosuppressive Agents
Hepatitis B Surface Antigens
Fibrosis
Therapeutics
Hepatitis
Hepatitis D
Chronic Hepatitis B
Azathioprine
Prednisone
Liver Diseases
Regeneration
Biopsy
Liver

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Chronic hepatitis in carriers of hepatitis B surface antigen, with intrahepatic expression of the delta antigen. An active and progressive disease unresponsive to immunosuppressive treatment. / Rizzetto, M.; Verme, G.; Recchia, S.; Bonino, F.; Farci, P.; Aricò, S.; Calzia, R.; Picciotto, A.; Colombo, M.; Popper, H.

In: Annals of Internal Medicine, Vol. 98, No. 4, 1983, p. 437-441.

Research output: Contribution to journalArticle

Rizzetto, M. ; Verme, G. ; Recchia, S. ; Bonino, F. ; Farci, P. ; Aricò, S. ; Calzia, R. ; Picciotto, A. ; Colombo, M. ; Popper, H. / Chronic hepatitis in carriers of hepatitis B surface antigen, with intrahepatic expression of the delta antigen. An active and progressive disease unresponsive to immunosuppressive treatment. In: Annals of Internal Medicine. 1983 ; Vol. 98, No. 4. pp. 437-441.
@article{352609ae4a9a4f829b94bdd4b3c0194f,
title = "Chronic hepatitis in carriers of hepatitis B surface antigen, with intrahepatic expression of the delta antigen. An active and progressive disease unresponsive to immunosuppressive treatment",
abstract = "To assess the characteristics of chronic hepatitis in hepatitis B surface antigen (HBsAg) carriers with intrahepatic delta antigen, the hepatic histologic findings of 137 patients were reviewed; 101 patients were followed for 2 to 6 years. The predominant liver disease was chronic active hepatitis in 93 patients or cirrhosis in 32; minor forms of chronic persistent or lobular hepatitis were seen in 12 patients. Eight of the 26 patients with an initial diagnosis of cirrhosis died during the follow-up period. Cirrhosis developed in 31 of 75 patients (41{\%}) without nodular regeneration seen in the first biopsy specimen; 5 of these patients died. Treatment with prednisone or azathioprine did not induce histologic amelioration of delta hepatitis or prevent cirrhosis. Chronic HBsAg hepatitis with intrahepatic expression of the delta antigen is an active, progressive disease unresponsive to conventional immunosuppressive treatment.",
author = "M. Rizzetto and G. Verme and S. Recchia and F. Bonino and P. Farci and S. Aric{\`o} and R. Calzia and A. Picciotto and M. Colombo and H. Popper",
year = "1983",
language = "English",
volume = "98",
pages = "437--441",
journal = "Annals of Internal Medicine",
issn = "0003-4819",
publisher = "American College of Physicians",
number = "4",

}

TY - JOUR

T1 - Chronic hepatitis in carriers of hepatitis B surface antigen, with intrahepatic expression of the delta antigen. An active and progressive disease unresponsive to immunosuppressive treatment

AU - Rizzetto, M.

AU - Verme, G.

AU - Recchia, S.

AU - Bonino, F.

AU - Farci, P.

AU - Aricò, S.

AU - Calzia, R.

AU - Picciotto, A.

AU - Colombo, M.

AU - Popper, H.

PY - 1983

Y1 - 1983

N2 - To assess the characteristics of chronic hepatitis in hepatitis B surface antigen (HBsAg) carriers with intrahepatic delta antigen, the hepatic histologic findings of 137 patients were reviewed; 101 patients were followed for 2 to 6 years. The predominant liver disease was chronic active hepatitis in 93 patients or cirrhosis in 32; minor forms of chronic persistent or lobular hepatitis were seen in 12 patients. Eight of the 26 patients with an initial diagnosis of cirrhosis died during the follow-up period. Cirrhosis developed in 31 of 75 patients (41%) without nodular regeneration seen in the first biopsy specimen; 5 of these patients died. Treatment with prednisone or azathioprine did not induce histologic amelioration of delta hepatitis or prevent cirrhosis. Chronic HBsAg hepatitis with intrahepatic expression of the delta antigen is an active, progressive disease unresponsive to conventional immunosuppressive treatment.

AB - To assess the characteristics of chronic hepatitis in hepatitis B surface antigen (HBsAg) carriers with intrahepatic delta antigen, the hepatic histologic findings of 137 patients were reviewed; 101 patients were followed for 2 to 6 years. The predominant liver disease was chronic active hepatitis in 93 patients or cirrhosis in 32; minor forms of chronic persistent or lobular hepatitis were seen in 12 patients. Eight of the 26 patients with an initial diagnosis of cirrhosis died during the follow-up period. Cirrhosis developed in 31 of 75 patients (41%) without nodular regeneration seen in the first biopsy specimen; 5 of these patients died. Treatment with prednisone or azathioprine did not induce histologic amelioration of delta hepatitis or prevent cirrhosis. Chronic HBsAg hepatitis with intrahepatic expression of the delta antigen is an active, progressive disease unresponsive to conventional immunosuppressive treatment.

UR - http://www.scopus.com/inward/record.url?scp=0020536993&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0020536993&partnerID=8YFLogxK

M3 - Article

C2 - 6340574

AN - SCOPUS:0020536993

VL - 98

SP - 437

EP - 441

JO - Annals of Internal Medicine

JF - Annals of Internal Medicine

SN - 0003-4819

IS - 4

ER -